How does an OCT scan help detect AMD changes? 

Optical Coherence Tomography, commonly referred to as an OCT scan, has revolutionised the way age related macular degeneration (AMD) is diagnosed and managed in the United Kingdom. Often described as a “window into the retina,” this non-invasive imaging technology allows clinicians to see beyond the surface of the eye and examine the individual layers of the macula in microscopic detail. Unlike traditional eye examinations that provide a two-dimensional view of the retina, an OCT scan creates a three-dimensional cross section, enabling eye specialists to identify the earliest structural changes associated with macular degeneration. In the UK, OCT is considered the gold standard for distinguishing between the “dry” and “wet” forms of the disease, providing the critical data needed to make life changing treatment decisions. 

What We’ll Discuss in This Article 

• The fundamental technology behind OCT and how it differs from a standard eye photo. 

• How OCT identifies the hallmark drusen of dry macular degeneration. 

• The specific role of OCT in detecting fluid and swelling in wet AMD. 

• Why cross-sectional imaging is essential for monitoring treatment response. 

• The importance of “retinal maps” in tracking the progression of geographic atrophy. 

• What a patient can expect during an OCT procedure in a UK clinic. 

The technology: Creating a 3D map of the macula 

Optical Coherence Tomography works similarly to ultrasound imaging, but instead of using sound waves, it uses light waves to capture high-resolution, cross-sectional images of the retina. During the scan, a beam of light is projected into the eye, and the machine measures how that light is reflected from the various tissues at the back of the eye. Because different layers of the retina reflect light differently, the OCT computer can compile this data into a detailed 3D map that shows the thickness and health of each individual layer. 

For a patient, this means the optometrist or ophthalmologist can look “under the hood” of the macula. While a standard retinal photograph might show the presence of pigment changes or large deposits, it cannot show the depth of those changes or whether there is fluid trapped between the layers. The precision of OCT is such that it can detect changes measured in micrometres (thousandths of a millimetre), allowing for the detection of AMD symptoms long before they are visible to the human eye through a traditional lens. Detailed information on retinal imaging technology is maintained by the NHS for patient education. 

Detecting the early markers: Drusen and retinal thinning 

In the diagnosis of dry AMD, the OCT scan is primarily used to identify and measure drusen. Drusen are small, yellow deposits of metabolic waste that accumulate underneath the retinal pigment epithelium (RPE), which is the supporting layer for the macula’s light sensitive cells. On an OCT scan, these appear as distinct “bumps” or elevations in the normally flat layers of the retina. By measuring the height and volume of these bumps, clinicians can determine whether the condition is in the early or intermediate stage. 

Beyond identifying drusen, the OCT scan helps detect the thinning of the retina, a process known as atrophy. As dry AMD progresses to its advanced stage, called geographic atrophy, the light sensitive cells and the supporting RPE layer begin to waste away. The OCT scan can clearly show these “missing” layers, appearing as areas where the retina is significantly thinner than average. This quantitative data is essential for UK specialists to track how quickly the disease is moving and to provide the patient with an accurate prognosis for their central vision. 

Identifying the “wet” transition: Fluid and swelling 

The most critical role of an OCT scan in the UK healthcare system is the rapid identification of wet AMD. This form of the disease occurs when abnormal, fragile blood vessels grow under the macula and leak fluid, proteins, or blood. This leakage causes the macula to swell, a condition known as macular oedema. On an OCT image, this fluid appears as dark, clear “pockets” or cysts within the retinal layers, or as a lifting of the entire macula away from its blood supply. 

Because wet AMD requires urgent treatment to prevent permanent scarring, the ability of the OCT to detect even tiny amounts of fluid is a significant clinical advantage. Often, an OCT scan can identify “subclinical” fluid leakage that is present but hasn’t yet caused the patient to notice a major change in their vision. Catching the transition from dry to wet AMD at this stage is the primary goal of the NICE guidance on AMD management, as starting treatment while the fluid levels are low leads to the best long term visual outcomes. 

Monitoring treatment response and stability 

For patients undergoing treatment for wet AMD, such as anti VEGF injections, the OCT scan becomes a routine part of every hospital visit. The scan is used to monitor the “activity” of the disease by checking if the pockets of fluid have dried up following an injection. If the OCT shows a flat, dry macula, it indicates that the treatment is working and the disease is stable. If the fluid reappears or increases, it signals to the ophthalmologist that another injection is required. 

This “treat and extend” or “pro re nata” (as needed) approach is the standard of care in the UK. Without the precise data from an OCT scan, doctors would have to rely on visual acuity tests alone, which are less sensitive and can be affected by factors like lighting or fatigue. The OCT provides an objective, biological measurement of the macula’s response to medication, ensuring that patients receive exactly the right amount of treatment to protect their sight without unnecessary procedures. The Macular Society provides further insights into how these scans guide clinical decision making. 

Geographic atrophy and autofluorescence mapping 

While OCT is the primary tool for fluid detection, it is also increasingly used to map the progression of advanced dry AMD, or geographic atrophy. By using specialized “en face” imaging modes, the OCT can create a top-down view of the atrophic patches, allowing specialists to calculate the exact square millimetre area of vision loss. This level of detail is becoming increasingly important in the UK as new treatments for geographic atrophy are researched and introduced. 

Some advanced OCT machines also perform fundus autofluorescence (FAF) mapping simultaneously. This technique identifies stressed retinal cells that are on the verge of dying, appearing as “bright” areas on the scan. By combining the 3D cross section of the OCT with the metabolic map of FAF, clinicians can gain a comprehensive understanding of the macula’s current state and its likely future progression. This dual approach is common in UK specialist eye centres and teaching hospitals. 

Summary of OCT Findings in AMD 

Feature Seen on OCT	Clinical Meaning	Typical Management
Small Elevations (Drusen)	Early-stage dry AMD	Routine monitoring every 12-24 months
Retinal Thinning	Progression of dry AMD	Assessment for low vision aids
Intraretinal Fluid (Cysts)	Active wet AMD (Leakage)	Urgent anti-VEGF injection therapy
Subretinal Fluid	Active wet AMD (Under retina)	Urgent anti-VEGF injection therapy
Retinal Pigment Epithelial Detachment	High risk dry or wet AMD	Close monitoring and specialist review
Fibrosis (Scarring)	Late-stage damage	Focus on maximizing remaining sight

What to expect during an OCT scan 

For the patient, having an OCT scan is a very straightforward and comfortable process. It is a non-invasive, “no touch” procedure that takes only a few minutes. You will be asked to sit in front of the machine and rest your chin and forehead on a support. The technician or optometrist will ask you to look at a small, coloured target (usually a green cross or a red light) inside the lens. 

As you focus on the target, the machine will scan your eye using a safe, low power light. You will not feel anything, and there are no bright flashes like those from a traditional camera. In some cases, your pupils may need to be dilated with drops to get a clearer image, which can make your vision slightly blurry for a few hours. In most UK high street opticians that offer OCT, the results are available instantly, allowing the optometrist to show you the 3D images of your retina and explain any findings immediately. 

Conclusion 

The OCT scan is the most powerful tool available for the early detection and ongoing monitoring of age-related macular degeneration in the United Kingdom. By providing a high resolution, 3D views of the macula’s internal structure, it allows clinicians to distinguish between dry and wet AMD with high precision, detect fluid leakage at the earliest possible stage, and tailor treatment plans to the individual patient’s needs. Whether it is identifying drusen in a routine check-up or monitoring the effect of injections in a hospital eye clinic, the OCT scan is fundamental to the modern effort to preserve sight. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot 

This article provides a medically accurate explanation of the role of OCT scanning in the diagnosis and management of AMD within the UK. It was written by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a UK trained physician with experience in internal medicine and acute care. The content is strictly aligned with the clinical standards of the NHS and the National Institute for Health and Care Excellence (NICE) for retinal health monitoring.